Abstract
Novel hexahydrospiro[piperidine-4,1'-pyrrolo[3,4-c]pyrroles that act as potent and selective orphanin FQ/nociceptin (N/OFQ) receptor (NOP) agonists were identified. The best compound, (+)-5a, potently inhibited 3H-N/OFQ binding to the NOP receptor (K(i) = 0.49 nM) but was >1000-fold less potent in binding to MOP, KOP, and DOP opiate receptors. Further, (+)-5a potently stimulated GTP gamma S binding to NOP membranes (EC50 = 65 nM) and inhibited forskolin-mediated cAMP accumulation in NOP-expressing cells (EC50 = 9.1 nM) with a potency comparable to that of the natural peptide agonist N/OFQ. These results indicate that (+)-5a is a highly selective and potent small-molecule full agonist of the NOP receptor.
MeSH terms
-
Binding, Competitive
-
Cell Line
-
Crystallography, X-Ray
-
Cyclic AMP / antagonists & inhibitors
-
Cyclic AMP / biosynthesis
-
Guanosine 5'-O-(3-Thiotriphosphate) / metabolism
-
Humans
-
Nociceptin Receptor
-
Pyridines / chemical synthesis*
-
Pyridines / chemistry
-
Pyridines / pharmacology
-
Pyrroles / chemical synthesis*
-
Pyrroles / chemistry
-
Pyrroles / pharmacology
-
Radioligand Assay
-
Receptors, Opioid / agonists*
-
Receptors, Opioid, delta / agonists
-
Receptors, Opioid, kappa / agonists
-
Receptors, Opioid, mu / agonists
-
Spiro Compounds / chemical synthesis*
-
Spiro Compounds / chemistry
-
Spiro Compounds / pharmacology
-
Stereoisomerism
-
Structure-Activity Relationship
Substances
-
1-(4-isopropylcyclohexyl)-5'-methyl-2'-phenylhexahydrospiro(piperidine-4,1'-pyrrolo(3,4-c)pyrrole)
-
Pyridines
-
Pyrroles
-
Receptors, Opioid
-
Receptors, Opioid, delta
-
Receptors, Opioid, kappa
-
Receptors, Opioid, mu
-
Spiro Compounds
-
Guanosine 5'-O-(3-Thiotriphosphate)
-
Cyclic AMP
-
Nociceptin Receptor
-
OPRL1 protein, human